靶向 KRAS G12V 的 T 细胞受体基因治疗晚期胰腺癌的单臂 1/2 期临床试验
T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.
80.1分
★★★★☆
站内排序·非疗效
FRONTIER PAPERS
T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients.
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。